7-Methoxy-1-indanone 97
- CAS NO.:34985-41-6
- Empirical Formula: C10H10O2
- Molecular Weight: 162.19
- MDL number: MFCD07784339
- EINECS: 233-305-4
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-09-12 18:53:35
What is 7-Methoxy-1-indanone 97?
The Uses of 7-Methoxy-1-indanone 97
7-Methoxy-1-indanone can be used to synthesize 10,15-Dihydro-4,9,14-trimethoxy-5H-diindeno[1,2-a;1′,2′-c]fluorene via acid-catalyzed trimerization.
General Description
7-Methoxy-1-indanone can be synthesized by using chroman-4-one as the starting material.
Properties of 7-Methoxy-1-indanone 97
| Melting point: | 99-102 °C |
| Boiling point: | 305℃ |
| Density | 1.166 |
| Flash point: | 147℃ |
| storage temp. | Sealed in dry,Room Temperature |
| form | solid |
| color | White to Yellow to Orange |
Safety information for 7-Methoxy-1-indanone 97
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H317:Sensitisation, Skin H319:Serious eye damage/eye irritation |
| Precautionary Statement Codes |
P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of soap and water. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for 7-Methoxy-1-indanone 97
| InChIKey | CZXBVBATQPHSSL-UHFFFAOYSA-N |
New Products
2-(2-Chlorophenyl)glycine Propiolic Acid 1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene (±)-amino(2-fluorophenyl)acetic acid trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 1-Pentadecanol 2,4-Dihydroxybenzaldehyde Dipropyl disulfide Pyrrolo[1,2-a]pyrimidine-6-carboxylic acid, 4,6,7,8-tetrahydro-4-oxo-, sodium salt (1:1), (6S) Obidoxime hydrochloride API 4 pentyn 1 ol N-Vinylformamide Methacrylate-PEG-Methacrylate, Mn:35000 2,4-Dihydroxyacetophenone 2-Chloro 5-Fluoro Pyridine Vasicinone 2-Chloroisonicotinic Acid Tween 80 or Polysorbate 80 2-Butyn-1-oL N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamide N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine Pirtobrutinib intd. 2-Pentyn-1-oL 4-NitrobenzotrifluorideRelated products of tetrahydrofuran
![7-(4-CHLOROPHENOXY)-2-[(3-METHYL-2-THIENYL)METHYLENE]-3-PHENYL-1-INDANONE](https://img.chemicalbook.in/StructureFile/ChemBookStructure2/GIF/CB2461555.gif)
![7-(4-CHLOROPHENOXY)-2-[(2,5-DIMETHYLANILINO)METHYLENE]-3-PHENYL-1-INDANONE](https://img.chemicalbook.in/StructureFile/ChemBookStructure2/GIF/CB2695015.gif)
![7-(4-CHLOROPHENOXY)-2-[(4-METHYLPHENYL)METHYLENE]-3-PHENYL-1-INDANONE](https://img.chemicalbook.in/StructureFile/ChemBookStructure2/GIF/CB1322372.gif)
![2-[(4-FLUOROPHENYL)METHYLENE]-7-(4-METHOXYPHENOXY)-3-PHENYL-1-INDANONE](https://img.chemicalbook.in/StructureFile/ChemBookStructure2/GIF/CB3261756.gif)

![7-(4-CHLOROPHENOXY)-2-[(2,5-DIFLUOROPHENYL)METHYLENE]-3-PHENYL-1-INDANONE](https://img.chemicalbook.in/StructureFile/ChemBookStructure2/GIF/CB2671349.gif)
![7-(4-METHOXYPHENOXY)-2-[(3-METHYL-2-THIENYL)METHYLENE]-3-PHENYL-1-INDANONE](https://img.chemicalbook.in/StructureFile/ChemBookStructure2/GIF/CB5740262.gif)
![2-[(3-BROMOPHENYL)METHYLENE]-7-(4-CHLOROPHENOXY)-3-PHENYL-1-INDANONE](https://img.chemicalbook.in/StructureFile/ChemBookStructure2/GIF/CB4670467.gif)
You may like
-
7-Methoxy-1-indanone CAS 34985-41-6View Details
34985-41-6 -
471-25-0 Propiolic Acid 98+View Details
471-25-0 -
84145-28-8 98+View Details
84145-28-8 -
trans-3-Benzyloxy-4-methoxy-beta-nitrostyrene 98+View Details
63909-29-5 -
2-(2-Chlorophenyl)glycine 88744-36-9 98+View Details
88744-36-9 -
40216-83-9 trans-4-Hydroxy-L-proline methyl ester hydrochloride 98+View Details
40216-83-9 -
629-76-5 98+View Details
629-76-5 -
1-(3-Hydroxy-4-methoxyphenyl)-2-nitroethene 98+View Details
39816-35-8
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

